Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Averitas Pharma was formed in 2018 as the USA commercial subsidiary of The Grünenthal Group, a multinational pharmaceutical company headquartered in Germany with a presence in more than 30 countries across Europe, Latin America and the USA. For more than 70 years, Grünenthal has been a global leader in the research and development of therapeutics for pain, gout and inflammation. The first innovative product in our portfolio ...
Averitas Pharma was formed in 2018 as the USA commercial subsidiary of The Grünenthal Group, a multinational pharmaceutical company headquartered in Germany with a presence in more than 30 countries across Europe, Latin America and the USA. For more than 70 years, Grünenthal has been a global leader in the research and development of therapeutics for pain, gout and inflammation. The first innovative product in our portfolio is Qutenza® (capsaicin) 8% patch, a non-opioid, which was acquired in late 2018.

List your booth number for exhibitions, ask us